Ausgabe 3/2014
Inhalt (24 Artikel)
Surgical management of breast cancer in BRCA-mutation carriers: a systematic review and meta-analysis
Antonis Valachis, Andreas D. Nearchou, Pehr Lind
Experiences and attitudes toward risk of recurrence testing in women with breast cancer: a systematic review
Laura E. Leggett, Diane L. Lorenzetti, Tom Noseworthy, Simran Tiwana, Gail MacKean, Fiona Clement
Breast cancer in Sub-Saharan Africa: opportunities for prevention
Louise A. Brinton, Jonine D. Figueroa, Baffour Awuah, Joel Yarney, Seth Wiafe, Shannon N. Wood, Daniel Ansong, Kofi Nyarko, Beatrice Wiafe-Addai, Joe Nat Clegg-Lamptey
Mammographic density—a review on the current understanding of its association with breast cancer
C. W. Huo, G. L. Chew, K. L. Britt, W. V. Ingman, M. A. Henderson, J. L. Hopper, E. W. Thompson
Primary breast tumor-derived cellular models: characterization of tumorigenic, metastatic, and cancer-associated fibroblasts in dissociated tumor (DT) cultures
Katherine Drews-Elger, Joeli A. Brinkman, Philip Miller, Sanket H. Shah, J. Chuck Harrell, Thiago G. da Silva, Zheng Ao, Amy Schlater, Diana J. Azzam, Kathleen Diehl, Dafydd Thomas, Joyce M. Slingerland, Charles M. Perou, Marc E. Lippman, Dorraya El-Ashry
SUMOylation proteins in breast cancer
Alaa T. Alshareeda, Ola H. Negm, Andrew R. Green, Christopher Nolan, Paddy Tighe, Nada Albarakati, Rebeka Sultana, Srinivasan Madhusudan, Ian O. Ellis, Emad A. Rakha
Detection and clinical relevance of hematogenous tumor cell dissemination in patients with ductal carcinoma in situ
Malgorzata Banys, Markus Hahn, Ines Gruber, Natalia Krawczyk, Markus Wallwiener, Andreas Hartkopf, Florin-Andrei Taran, Carmen Röhm, Ralf Kurth, Sven Becker, Erich-Franz Solomayer, Diethelm Wallwiener, Annette Staebler, Tanja Fehm
Immune cell quantitation in normal breast tissue lobules with and without lobulitis
Amy C. Degnim, Rushin D. Brahmbhatt, Derek C. Radisky, Tanya L. Hoskin, Melody Stallings-Mann, Mark Laudenschlager, Aaron Mansfield, Marlene H. Frost, Linda Murphy, Keith Knutson, Daniel W. Visscher
Hepatic nonparenchymal cells drive metastatic breast cancer outgrowth and partial epithelial to mesenchymal transition
Donald P. Taylor, Amanda Clark, Sarah Wheeler, Alan Wells
Combined analysis of gene expression, DNA copy number, and mutation profiling data to display biological process anomalies in individual breast cancers
Weiwei Shi, Balint Balazs, Balazs Györffy, Tingting Jiang, W. Fraser Symmans, Christos Hatzis, Lajos Pusztai
Optimum duration of neoadjuvant letrozole to permit breast conserving surgery
Robert Carpenter, Julie C. Doughty, Carolyn Cordiner, Nuala Moss, Ashu Gandhi, Chris Wilson, Chris Andrews, Gillian Ellis, Gerald Gui, Anthony I. Skene
Should we screen BRCA1 mutation carriers only with MRI? A multicenter study
Inge-Marie Obdeijn, Gonneke A. O. Winter-Warnars, Ritse M. Mann, Maartje J. Hooning, M. G. Myriam Hunink, Madeleine M. A. Tilanus-Linthorst
31P magnetic resonance spectroscopy of the breast and the influence of the menstrual cycle
B. L. Stehouwer, W. J. M. van der Kemp, P. R. Luijten, M. A. A. J. van den Bosch, W. B. Veldhuis, J. P. Wijnen, D. W. J. Klomp
Biomarker prediction of chemotherapy-related amenorrhea in premenopausal women with breast cancer participating in E5103
Kathryn J. Ruddy, Anne O’Neill, Kathy D. Miller, Bryan P. Schneider, Emily Baker, Joseph A. Sparano, Chau Dang, Donald W. Northfelt, George W. Sledge Jr., Ann H. Partridge
Germline variants in the CYP19A1 gene are related to specific adverse events in aromatase inhibitor users: a substudy of Dutch patients in the TEAM trial
Duveken B. Y. Fontein, Daniel Houtsma, Johan W. R. Nortier, Renee F. Baak-Pablo, Elma Meershoek-Klein Kranenbarg, Tahar R. J. H. M. van der Straaten, Hein Putter, Caroline Seynaeve, Hans Gelderblom, Cornelis J. H. van de Velde, Henk-Jan Guchelaar
The clinical utility of genetic testing in breast cancer kindreds: a prospective study in families without a demonstrable BRCA mutation
Pål Møller, Astrid Stormorken, Marit Muri Holmen, Anne Irene Hagen, Anita Vabø, Lovise Mæhle
A phase II, multicentre trial evaluating the efficacy of de-escalated bisphosphonate therapy in metastatic breast cancer patients at low-risk of skeletal-related events
Christina L. Addison, Nathaniel Bouganim, John Hilton, Lisa Vandermeer, Susan Dent, Eitan Amir, Sean Hopkins, Iryna Kuchuk, Roanne Segal, Xinni Song, Stan Gertler, Sasha Mazzarello, George Dranitsaris, Daylily Ooi, Gregory Pond, Mark Clemons
Heterogeneity of breast cancer subtypes and survival among Hispanic women with invasive breast cancer in California
Matthew P. Banegas, Li Tao, Sean Altekruse, William F. Anderson, Esther M. John, Christina A. Clarke, Scarlett L. Gomez
Recurrent mutation testing of BRCA1 and BRCA2 in Asian breast cancer patients identify carriers in those with presumed low risk by family history
Peter Choon Eng Kang, Sze Yee Phuah, Kavitta Sivanandan, In Nee Kang, Eswary Thirthagiri, Jian Jun Liu, Norhashimah Hassan, Sook-Yee Yoon, Meow Keong Thong, Miao Hui, Mikael Hartman, Cheng Har Yip, Nur Aishah Mohd Taib, Soo Hwang Teo
Comprehensive evaluation of the incidence of late effects in 5-year survivors of breast cancer
Timothy L. Lash, Soe Soe Thwin, Marianne Ulcickas Yood, Ann M. Geiger, Jaclyn Bosco, Virginia P. Quinn, Terry S. Field, Pamala A. Pawloski, Rebecca A. Silliman
Adjuvant chemotherapy dosing in low-income women: the impact of Hispanic ethnicity and patient self-efficacy
Jennifer J. Griggs, Yihang Liu, Melony E. Sorbero, Christina H. Jagielski, Rose C. Maly
Early treatment discontinuation and switching in first-line metastatic breast cancer: the role of patient-reported symptom burden
Mark S. Walker, Anthony S. Masaquel, Jiandong Kerr, Deepa Lalla, Oyewale Abidoye, Arthur C. Houts, Lee S. Schwartzberg
Prevalence of breast cancer in thyroid diseases: results of a cross-sectional study of 3,921 patients
Natalie Prinzi, Enke Baldini, Salvatore Sorrenti, Corrado De Vito, Chiara Tuccilli, Antonio Catania, Sabino Carbotta, Renzo Mocini, Carmela Coccaro, Angela Nesca, Marta Bianchini, Enrico De Antoni, Massimino D’Armiento, Salvatore Ulisse
Race and breast cancer survival by intrinsic subtype based on PAM50 gene expression
Candyce H. Kroenke, Carol Sweeney, Marilyn L. Kwan, Charles P. Quesenberry, Erin K. Weltzien, Laurel A. Habel, Adrienne Castillo, Phillip S. Bernard, Rachel E. Factor, Lawrence H. Kushi, Bette J. Caan